Courtesy of Dr. Carlos Fava. Surgical aortic valve replacement with bioprosthesis has proved its benefits, but it fails after 10 to 15 years. Transcatheter aortic valve replacement has been shown valid, especially in high risk patients, but we still have little information and no “head to head” studies to know what is best in this<a href="https://solaci.org/en/2020/08/04/valve-in-valve-presents-better-evolution-than-re-sarv/" title="Read more" >...</a>
2° Educational Meetings ProEducar-SOLACI | Aortic Valve Implantation. Step by Step. Complications
We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
After 8-year Followup, Good News for the Self Expandable Valve
As the transcatheter aortic valve replacement (TAVR) gains ground in lower risk populations and with better survival rate, concern over its durability has grown. This study brings us data and good news on the first-generation self-expandable valve after quite a long follow up. It included 990 inoperable or high-risk patients treated with CoreValve in 8<a href="https://solaci.org/en/2020/07/22/after-8-year-followup-good-news-for-the-self-expandable-valve/" title="Read more" >...</a>
1° ProEducar Educational Meetings | Aortic Valve Implantation. Step by Step. Complications
Watch again our Webinar on “Aortic Valve Implantation. Step by Step. Complications” on our Youtube account. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
EuroPCR 2020 | Aortic Valve in Valve in the Long Term
The outcomes of this work are important to plan valve replacement with the largest possible prosthesis allowed by patient anatomy in the index procedure. As a worldwide trend, increasingly more patients are receiving bioprostheses, which have improved a lot but still tend to become deteriorated and require a valve-in-valve procedure if the patient is no<a href="https://solaci.org/en/2020/07/13/europcr-2020-aortic-valve-in-valve-in-the-long-term/" title="Read more" >...</a>
ProEducar Educational Meetings | Aortic Valve Implantation, Step by Step and Complications
We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.
EuroPCR 2020 | EVOQUE: New Transcatheter Mitral Valve Replacement System, Promises at Short Term and Future Hope
Transeptal transcatheter mitral valve replacement offers a less invasive alternative vs. surgery and with fewer anatomical limitations than transcatheter repair (e.g. MitraClip) in patients with severe mitral valve failure. The first patients treated with the new system EVOQUE were included between September 2018 and October 2019 and its outcomes were presented at the virtual EuroPCR<a href="https://solaci.org/en/2020/07/08/europcr-2020-evoque-new-transcatheter-mitral-valve-replacement-system-promises-at-short-term-and-future-hope/" title="Read more" >...</a>
Self-Expanding Valve vs. Balloon-Expandable Valve, Randomized, Head to Head
The “arms race”among transcatheter valves has been vertiginous. By the time we received the mid- or long-term outcomes of studies focused on a given valve, we were already using its next generation in clinical practice. As a result, there is little information addressing which valve is the best. Nowadays, this “arms race” has reached a<a href="https://solaci.org/en/2020/06/24/self-expanding-valve-vs-balloon-expandable-valve-randomized-head-to-head/" title="Read more" >...</a>
Frailty and Bleeding: Impact on Aortic Valve Replacement
Courtesy of Dr. Carlos Fava. We are well aware that both transcatheter aortic valve replacement (TAVR) and surgical valve replacement (SAVR) generate bleeding (15% to 22% for TAVR and 22% to 44% for SAVR). Frail patients constitute a particular group. These have not yet been assessed as to the real risk they run and mortality<a href="https://solaci.org/en/2020/06/09/frailty-and-bleeding-impact-on-aortic-valve-replacement/" title="Read more" >...</a>
TAVR: Balloon-Expandable or Self-Expanding Valves, Which Is the Answer?
Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) has shown benefit and is currently moving towards low-risk patients, as well as bicuspid aortic valves and (to a lower extent) aortic regurgitation. However, we must ponder on which valve should be used on each patient: balloon-expandable (BE) or self-expanding (SE) valve? They represent different technologies<a href="https://solaci.org/en/2020/06/03/tavr-balloon-expandable-or-self-expanding-valves-which-is-the-answer/" title="Read more" >...</a>